相关实验视频
Updated: May 27, 2025

09:26
The Monoiodoacetate Model of Osteoarthritis Pain in the Mouse
Published on: May 16, 2016
34.9K
治疗骨关节炎疼痛的抗抑郁药:疼痛表型的价值
Di Zhang1,2, Leticia A Deveza3,4, Bryan Yijia Tan5
1The Second Affiliated Hospital, Xi'an Jiaotong University, Xi'an, People's Republic of China.
Drugs & aging
|February 20, 2025
概括
骨关节炎疼痛管理需要更好的策略. 使用疼痛表型和抗抑郁药 (如SNRIs) 进行个性化治疗,有望改善OA患者的生活质量.
科学领域:
- 风湿病学和疼痛管理
- 药理学 药理学是指药理学的学科.
- 精神病学是一个精神病学.
背景情况:
- 骨关节炎 (OA) 显著影响生活质量,导致疼痛,活动减少和残疾,影响全球5.95亿人.
- 目前的OA疼痛治疗方法 (NSAID,阿片类药物) 提供有限的缓解,并带有风险.
- 心理社会因素 (焦虑,抑郁) 和患者异质性往往被忽视,加剧了OA的疼痛.
研究的目的:
- 突出需要改进的OA疼痛管理策略.
- 探索疼痛表型化对于个性化OA治疗的潜力.
- 调查抗抑郁药,特别是SNRIs在治疗OA疼痛和心理症状中的作用.
主要方法:
- 审查当前的OA治疗限制.
- 讨论疼痛表型作为患者分层的方法.
- 在OA患者中分析抗抑郁药的疗效,特别是SNRIs.
主要成果:
- 由于患者的异质性和心理社会因素,现有的OA治疗方法往往不足.
- 疼痛表型化为量身定制治疗以满足个体患者需求提供了一条途径.
- 抗抑郁药 (SNRIs) 在OA患者中显示出潜在的但具有可变的有效性.
结论:
- 标准化疼痛表型对于优化OA中抗抑郁药物治疗至关重要.
- 需要个性化治疗方法来提高OA疼痛管理的疗效并最大限度地减少副作用.
- 需要进一步的研究,将疼痛表型与抗抑郁药物选择相结合,以获得更好的OA结果.
相关概念视频
Analgesia and Pain Management
422
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
422
Opioid Analgesics: Synthetic and Semisynthetic Opioids
207
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
207
Antidepressant Drugs: MAOIs and Other Agents
181
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
181
Opioid Analgesics: Morphine and Other Natural Cogeners
165
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
165
Nociception
27.7K
Nociception—the ability to feel pain—is essential for an organism’s survival and overall well-being. Noxious stimuli such as piercing pain from a sharp object, heat from an open flame, or contact with corrosive chemicals are first detected by sensory receptors, called nociceptors, located on nerve endings. Nociceptors express ion channels that convert noxious stimuli into electrical signals. When these signals reach the brain via sensory neurons, they are perceived as pain.
27.7K
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
280
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
280

